Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Santen Pharmaceutical patents glucocorticoid receptor agonists

March 24, 2017

Mouse model developed for the study of alpha-gal meat allergy

March 14, 2017

TiGenix initiates phase Ib/IIa trial of Cx-611 to treat sepsis in community-acquired pneumonia

Jan. 31, 2017

Eagle Pharmaceuticals completes NDA submission for Ryanodex

Jan. 24, 2017

AnaMar reports 5-HT2B receptor antagonists

Jan. 17, 2017

AdAlta reports additional preclinical data for AD-114 in lung and liver fibrosis

Jan. 11, 2017

Mutations in FAM105B gene may be involved in autoinflammatory diseases

Nov. 29, 2016

Actelion Pharmaceuticals describes TPHI1 inhibitors

Nov. 22, 2016

Eagle Pharmaceuticals initiates rolling NDA for Ryanodex in EHS

Nov. 14, 2016

University of California develops anti-alphavbeta1 integrin inhibitors

Sep. 28, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.